{{Rsnum
|rsid=17300741
|Gene=SLC22A11
|Chromosome=11
|position=64563990
|Orientation=plus
|GMAF=0.337
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC22A11
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 44.2 | 31.0
| HCB | 86.1 | 13.1 | 0.7
| JPT | 88.5 | 10.6 | 0.9
| YRI | 37.4 | 47.6 | 15.0
| ASW | 40.4 | 40.4 | 19.3
| CHB | 86.1 | 13.1 | 0.7
| CHD | 89.9 | 10.1 | 0.0
| GIH | 34.7 | 48.5 | 16.8
| LWK | 38.2 | 50.9 | 10.9
| MEX | 55.2 | 34.5 | 10.3
| MKK | 38.5 | 44.2 | 17.3
| TSI | 28.4 | 42.2 | 29.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19503597
|Trait=Uric acid concentrations
|Title=Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations
|RiskAllele=A
|Pval=7E-14
|OR=0.06
|ORtxt=[0.046-0.078] mg/dl increase
|OA=1
}}

{{PMID Auto
|PMID=19890391
|Title=Common polymorphisms influencing serum uric Acid levels contribute to susceptibility to gout, but not to coronary artery disease
|OA=1
}}

{{PMID Auto
|PMID=19861489
|Title=Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms.
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17300741
|overall_frequency_n=56
|overall_frequency_d=128
|overall_frequency=0.4375
|n_genomes=33
|n_genomes_annotated=0
|n_haplomes=46
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=23712608
|Title=Genetic variability related to serum uric acid concentration and risk of Parkinson's disease.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}